WuXi Biologics 1. Juni 2026 BRIEF: WuXi Biologics maintains full-year revenue guidance for up to 17% growth - thebambooworks.com
WuXi Biologics 27. Mai 2026 Viridian, awaiting FDA decision, taps WuXi Bio in supply deal - Fierce Pharma
WuXi Biologics 27. Mai 2026 WuXi Biologics Shanghai Drug Product Facility Achieves GMP Release - Contract Pharma
WuXi Biologics 20. Mai 2026 WuXi Biologics Hosts Third CRDMO Day in Japan, Accelerating Biopharma Innovation from IND to Commercialization - The Manila Times
WuXi Biologics 20. Mai 2026 WuXi Biologics Hosts Third CRDMO Day in Japan, Accelerating Biopharma Innovation from IND to Commercialization - Yahoo Finance
WuXi Biologics 8. Mai 2026 WuXi Biologics Chengdu Milestone Raises Questions On Capacity Use And Returns - simplywall.st
WuXi Biologics 8. Mai 2026 WuXi Biologics Chengdu Milestone Raises Questions On Capacity Use And Returns - simplywall.st
WuXi Biologics 2. Mai 2026 WuXi Biologics Advances Global Sustainability Strategy With 2025 ESG Report - BioPharma APAC
WuXi Biologics 1. Mai 2026 Is WuXi Biologics (SEHK:2269) Attractive After Its Five Year Share Price Reset? - simplywall.st
WuXi Biologics 30. Apr. 2026 WuXi Biologics Advances Global Sustainability Strategy With 2025 ESG Report - BioPharma APAC
WuXi Biologics 30. Apr. 2026 WuXi Biologics Advances Global Sustainability Strategy With 2025 ESG Report - BioPharma APAC
WuXi Biologics 25. Apr. 2026 WuXi Biologics Secures MFDS GMP Certification For Three Key Manufacturing Facilities - BioPharma APAC
WuXi Biologics 24. Apr. 2026 WuXi Biologics Secures MFDS GMP Certification For Three Key Manufacturing Facilities - BioPharma APAC
WuXi Biologics 24. Apr. 2026 WuXi Biologics Completes Structure of Chengdu Microbial Manufacturing Site - Contract Pharma
WuXi Biologics 17. Apr. 2026 WuXi Biologics Recognized as ESG Leader by Morningstar Sustainalytics - Contract Pharma
WuXi Biologics 17. Apr. 2026 WuXi Biologics Recognized by Morningstar Sustainalytics as Industry and Regional ESG Leader for Sixth Year - Barchart.com
WuXi Biologics 17. Apr. 2026 WuXi Biologics Recognized by Morningstar Sustainalytics as Industry and Regional ESG Leader for Sixth Year - PR Newswire
WuXi Biologics 15. Apr. 2026 WuXi Biologics Secures ISO 13485 Certification With Zero Non Conformities Strengthening Combination Product Capabilities - BioPharma APAC